FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3032917529> ?p ?o ?g. }

• W3032917529 endingPage "849" @default.
• W3032917529 startingPage "849.2" @default.
• W3032917529 abstract "Background: FMF is an autosomal recessive disorder. Systemic inflammation in autoinflammatory disorders cause secondary systemic AA amyloidosis, which has been suggested as an important contributing factor to the excess cardiovascular disease (CVD) risk in patients with FMF. Objectives: Our aim was to investigate the CVD-related clinical outcomes in patients with FMF-related amyloidosis and to define risk factors for CVD events (CVDEs). Methods: A cross-sectional evaluation with prospective follow-up of consecutive patients with FMF-related amyloidosis or other non-diabetic primary glomerulonephropathy (PGN) was performed. Patients were followed for CVDEs. Flow-mediated dilatation (FMD), FGF-23 levels, serum lipid levels, hsCRP, BMI and homeostasis model assessment (HOMA) were assessed. A Cox regression analysis was performed to evaluate the probability of CVDEs associated with each risk factor. Results: There were 107 patients in FMF-related amyloidosis group and 126 patients with PGN group. Forty-seven CVDEs were registered during the 4.2-years follow up; all 28 patients in the FMF-related amyloidosis versus 14/19 patients with PGN group who developed CVDEs before 40 years of age (P=0.002) (Figure 1). CVD mortality was 2.8 times higher (95% CI 1.02-7.76, p=0.03) in patients with FMF-related amyloidosis (n=12) than PGN (n=5). Mortality due to CVD was higher in patients less than 40 years old with amyloidosis than PGN (12/107 and 3/126 respectively, RR=4.71, 95% CI 1.36-16.25, p=0.006). Patients with CVDEs had higher levels of proteinuria, hsCRP and FGF23, and lower FMD compared to patients without CVDEs. Across both groups, FGF23 and FMD levels were independently associated with the risk of CVDEs (Table 1). Table 1. Multivariate analysis of factors associated with the risk of suffering a cardiovascular event B HR 95.0% CI for Exp(B) p Variables Lower Upper All Groups FGF23 .033 1.034 1.017 1.051 <.001 FMD -.946 .388 .262 .575 <.001 Primary FGF23 .050 1.051 1.019 1.084 .002 glomerulopathy FMD -.651 .522 .300 .908 .021 Amyloidosis FGF23 .034 1.035 1.012 1.058 .003 FMD -1.531 .216 .109 .430 <.001 hsCRP -.040 .961 .915 1.009 .108 FMD, Flow-mediated dilatation; hsCRP, high sensitivity C reactive protein; CI, Confidence interval Figure 1. Comparison of cardiovascular disease survival between patients with FMF-related amyloidosis or primary glomerulopathy. Conclusion: Patients with FMF-related amyloidosis are at increased risk of CVDEs with early mortality age. These patients should be closely monitored and if inflammation is poorly controlled with colchicine, biological agents must be added to treatment even if they develop amyloidosis. We also found that hsCRP, FGF 23 and FMD levels were the strongest predictors of CVD risk in patients with FMF. These biomarkers can stratify risk of early CVD in patients with FMF-related amyloidosis. References: [1] Yilmaz, M.I., et al., Endothelial function in patients with familial Mediterranean fever-related amyloidosis and association with cardiovascular events. Rheumatology (Oxford), 2014. 53 (11): p. 2002-8. Disclosure of Interests: None declared" @default.
• W3032917529 created "2020-06-12" @default.
• W3032917529 creator A5000636712 @default.
• W3032917529 creator A5009854348 @default.
• W3032917529 creator A5013004784 @default.
• W3032917529 creator A5029946748 @default.
• W3032917529 creator A5032187087 @default.
• W3032917529 creator A5037962183 @default.
• W3032917529 creator A5043887994 @default.
• W3032917529 date "2020-06-01" @default.
• W3032917529 modified "2023-10-16" @default.
• W3032917529 title "FRI0501 CARDIOVASCULAR DISEASE RISK ASSESSMENT IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER RELATED AMYLOIDOSIS" @default.
• W3032917529 cites W1926049969 @default.
• W3032917529 doi "https://doi.org/10.1136/annrheumdis-2020-eular.3369" @default.
• W3032917529 hasPublicationYear "2020" @default.
• W3032917529 type Work @default.
• W3032917529 sameAs 3032917529 @default.
• W3032917529 citedByCount "0" @default.
• W3032917529 crossrefType "journal-article" @default.
• W3032917529 hasAuthorship W3032917529A5000636712 @default.
• W3032917529 hasAuthorship W3032917529A5009854348 @default.
• W3032917529 hasAuthorship W3032917529A5013004784 @default.
• W3032917529 hasAuthorship W3032917529A5029946748 @default.
• W3032917529 hasAuthorship W3032917529A5032187087 @default.
• W3032917529 hasAuthorship W3032917529A5037962183 @default.
• W3032917529 hasAuthorship W3032917529A5043887994 @default.
• W3032917529 hasBestOaLocation W30329175291 @default.
• W3032917529 hasConcept C126322002 @default.
• W3032917529 hasConcept C188816634 @default.
• W3032917529 hasConcept C2776914184 @default.
• W3032917529 hasConcept C2777007455 @default.
• W3032917529 hasConcept C2779134260 @default.
• W3032917529 hasConcept C2779537928 @default.
• W3032917529 hasConcept C2779561371 @default.
• W3032917529 hasConcept C2779951007 @default.
• W3032917529 hasConcept C2780091579 @default.
• W3032917529 hasConcept C50382708 @default.
• W3032917529 hasConcept C50440223 @default.
• W3032917529 hasConcept C55359608 @default.
• W3032917529 hasConcept C71924100 @default.
• W3032917529 hasConcept C90924648 @default.
• W3032917529 hasConceptScore W3032917529C126322002 @default.
• W3032917529 hasConceptScore W3032917529C188816634 @default.
• W3032917529 hasConceptScore W3032917529C2776914184 @default.
• W3032917529 hasConceptScore W3032917529C2777007455 @default.
• W3032917529 hasConceptScore W3032917529C2779134260 @default.
• W3032917529 hasConceptScore W3032917529C2779537928 @default.
• W3032917529 hasConceptScore W3032917529C2779561371 @default.
• W3032917529 hasConceptScore W3032917529C2779951007 @default.
• W3032917529 hasConceptScore W3032917529C2780091579 @default.
• W3032917529 hasConceptScore W3032917529C50382708 @default.
• W3032917529 hasConceptScore W3032917529C50440223 @default.
• W3032917529 hasConceptScore W3032917529C55359608 @default.
• W3032917529 hasConceptScore W3032917529C71924100 @default.
• W3032917529 hasConceptScore W3032917529C90924648 @default.
• W3032917529 hasIssue "Suppl 1" @default.
• W3032917529 hasLocation W30329175291 @default.
• W3032917529 hasOpenAccess W3032917529 @default.
• W3032917529 hasPrimaryLocation W30329175291 @default.
• W3032917529 hasRelatedWork W2020472748 @default.
• W3032917529 hasRelatedWork W2037482578 @default.
• W3032917529 hasRelatedWork W2057433251 @default.
• W3032917529 hasRelatedWork W2118943251 @default.
• W3032917529 hasRelatedWork W2129948135 @default.
• W3032917529 hasRelatedWork W2130682857 @default.
• W3032917529 hasRelatedWork W2180891493 @default.
• W3032917529 hasRelatedWork W3022962463 @default.
• W3032917529 hasRelatedWork W3112311115 @default.
• W3032917529 hasRelatedWork W4283524538 @default.
• W3032917529 hasVolume "79" @default.
• W3032917529 isParatext "false" @default.
• W3032917529 isRetracted "false" @default.
• W3032917529 magId "3032917529" @default.
• W3032917529 workType "article" @default.